Khera et al. have found that carriers of an identified FH-causing mutation who suffer from severe hypercholesterolemia had an enhanced CVD risk in comparison to severe hypercholesterolemia patients who did not carry the identified mutation. This evidence concerns the gene FH and Hypercholesterolemia.